Detalhe da pesquisa
1.
Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma.
Front Oncol
; 13: 1208403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916165
2.
Partners in crime: The feedback loop between metabolic reprogramming and immune checkpoints in the tumor microenvironment.
Front Oncol
; 12: 1101503, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713558
3.
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment.
Front Endocrinol (Lausanne)
; 13: 929572, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072935
4.
Old and New Players of Inflammation and Their Relationship With Cancer Development.
Front Oncol
; 11: 722999, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881173
5.
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines.
Front Oncol
; 11: 750677, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34966671
6.
miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.
Viruses
; 14(1)2021 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062245
7.
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity.
Front Oncol
; 10: 578418, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33117715
8.
Contribution of Angiogenesis to Inflammation and Cancer.
Front Oncol
; 9: 1399, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921656
9.
Relationship of dendritic cell density, HMGB1 expression, and tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Appl Immunohistochem Mol Morphol
; 22(2): 105-13, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752173